Can SGLT2i use decrease the risk of atrial fibrillation in patients with heart failure with reduced ejection fraction: a retrospective cohort study

被引：0
|
作者：
Alejandro, J. [1 ]
Beloy, F. [2 ]
Khachatryan, A. [1 ]
Cinar, T. [1 ]
机构：
[1] Univ Maryland, Midtown Campus, Baltimore, MD USA
[2] Ateneo Sch Med & Publ Hlth, Pasig, Philippines
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [21] SGLT2i Use in Pediatric Heart Failure: Multicenter Study
    Butts, R.
    Nandi, D.
    Hong, B.
    Lorts, A.
    Profita, E.
    Spinner, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S149 - S149
  • [22] SGLT2i and Cardiovascular Events in Patients With Concomitant Atrial Fibrillation and Diabetes: A TriNetX Cohort Study
    Hsiao, Yu-Yu
    Chen, Yun-Yu
    Kuo, Ming-Jen
    Chien, Yu-Shan
    Li, Guan-Yi
    Wu, Shang-Ju
    Lin, Wei-Lun
    Chiu, Shu-Fen
    Li, Cheng-Hung
    Lin, Jiunn-Cherng
    Lin, Ching-Heng
    Huang, Jin-Long
    Hsieh, Yu-Cheng
    Chen, Shih-Ann
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2025,
  • [23] SGLT2 INHIBITOR USE IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION AND HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF): A PROPENSITY SCORE MATCHED (PSM) ANALYSIS
    Anuforo, Anderson C.
    Rawlley, Bharat
    Diez, Armando Pichs
    Menezes, Sherna B.
    Ngembus, Ngonack Joan
    Draytsel, Dan
    Palanivel, Kavipriya Kovai
    Ugoala, Onyinye Sylvia
    Ebubechukwu, Ugochukwu Jerome
    Paulraj, Shweta
    Charlamb, Mark J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 51 - 51
  • [24] Obesity Paradox among Heart Failure with Reduced Ejection Fraction Patients: A Retrospective Cohort Study
    Alrob, Osama Abo
    Sankaralingam, Sowndramalingam
    Alazzam, Sayer
    Nusairat, Buthaina
    Qattoum, Muhammad
    Nusair, Mohammad B. B.
    MEDICINA-LITHUANIA, 2023, 59 (01):
  • [25] Atrial fibrillation and heart failure with non reduced ejection fraction: can biomarkers make the difference?
    Merino, A. Merino
    Perez Rivera, J. A.
    De La Maleta Ubeda, R. Saez
    Salgado Aranda, R.
    Pascual Tejerina, V.
    Martin Gonzalez, J.
    Garcia Fernandez, J.
    Al Kassam Martinez, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 46 - 46
  • [26] Ivabradine in heart failure patients with reduced ejection fraction and history of paroxysmal atrial fibrillation
    Lin, Yu-Sheng
    Jan, Jeng-Yu
    Chang, Jung-Jung
    Lin, Ming-Shyan
    Yang, Teng-Yao
    Wang, Po-Chang
    Chen, Mien-Cheng
    ESC HEART FAILURE, 2022, 9 (04): : 2548 - 2557
  • [27] Impact of atrial fibrillation ablation in heart failure with reduced ejection fraction
    Massa, M. P.
    Arias, R. M.
    Spaccavento, A.
    Ballari, F. N.
    Burgos, L. M.
    Diez, M.
    Espinoza, J. C.
    Ramirez, A. J. Gil
    Mondragon, L. I.
    Albina, G.
    Scazzuso, F.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [28] Spironolactone and Incidence of Atrial Fibrillation in Heart Failure with Reduced Ejection Fraction
    Chami, Tarek
    Kim, Chang H.
    Tefera, Leben
    Alencherry, Ben
    Darmoch, Fahed
    Al-Kindi, Sadeer G.
    Oliveira, Guilherme H.
    JOURNAL OF CARDIAC FAILURE, 2017, 23 (08) : S71 - S71
  • [29] Rhythm Control of Atrial Fibrillation in Heart Failure with Reduced Ejection Fraction
    Gregory Burkman
    Gerald V. Naccarelli
    Current Cardiology Reports, 2020, 22
  • [30] Catheter ablation of atrial fibrillation in heart failure with reduced ejection fraction
    Malhi, Nav
    Hawkins, Nathaniel M.
    Andrade, Jason G.
    Krahn, Andrew D.
    Deyell, Marc W.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2018, 29 (07) : 1049 - 1058
12345